Nahdi Medical Company (TADAWUL:4164)
Saudi Arabia
· Delayed Price · Currency is SAR 100.30
+4.00 (4.15%)
At close: Dec 4, 2025
Nahdi Medical Company Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 13,039 | 15,288 | 17,810 | 21,736 | - | - | Upgrade
|
| Market Cap Growth | -16.28% | -14.16% | -18.06% | - | - | - | Upgrade
|
| Enterprise Value | 14,200 | 16,025 | 17,991 | 22,301 | - | - | Upgrade
|
| Last Close Price | 100.30 | 112.12 | 125.55 | 148.18 | - | - | Upgrade
|
| PE Ratio | 16.04 | 18.63 | 19.95 | 24.48 | - | - | Upgrade
|
| Forward PE | 15.15 | 17.51 | 20.42 | 23.26 | - | - | Upgrade
|
| PS Ratio | 1.31 | 1.62 | 2.04 | 2.52 | - | - | Upgrade
|
| PB Ratio | 5.18 | 5.91 | 7.23 | 9.69 | - | - | Upgrade
|
| P/TBV Ratio | 5.33 | 6.07 | 7.39 | 9.90 | - | - | Upgrade
|
| P/FCF Ratio | 13.00 | 13.27 | 18.51 | 15.33 | - | - | Upgrade
|
| P/OCF Ratio | 9.29 | 10.25 | 13.53 | 13.03 | - | - | Upgrade
|
| PEG Ratio | 3.78 | 6.95 | 6.59 | 3.46 | - | - | Upgrade
|
| EV/Sales Ratio | 1.42 | 1.70 | 2.07 | 2.59 | - | - | Upgrade
|
| EV/EBITDA Ratio | 8.57 | 14.18 | 15.24 | 18.71 | - | - | Upgrade
|
| EV/EBIT Ratio | 15.62 | 18.38 | 18.73 | 22.31 | - | - | Upgrade
|
| EV/FCF Ratio | 14.16 | 13.91 | 18.70 | 15.73 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.72 | 0.59 | 0.48 | 0.52 | 0.85 | 0.59 | Upgrade
|
| Debt / EBITDA Ratio | 1.08 | 0.99 | 0.76 | 0.74 | 0.93 | 0.85 | Upgrade
|
| Debt / FCF Ratio | 1.79 | 1.33 | 1.22 | 0.82 | 1.29 | 0.96 | Upgrade
|
| Asset Turnover | 1.58 | 1.64 | 1.69 | 1.87 | 1.80 | 1.95 | Upgrade
|
| Inventory Turnover | 3.29 | 3.85 | 4.07 | 4.47 | 4.26 | 4.77 | Upgrade
|
| Quick Ratio | 0.37 | 0.55 | 0.66 | 0.80 | 0.42 | 0.78 | Upgrade
|
| Current Ratio | 1.41 | 1.55 | 1.69 | 1.70 | 1.40 | 1.72 | Upgrade
|
| Return on Equity (ROE) | 33.00% | 32.51% | 37.93% | 46.16% | 44.13% | 43.96% | Upgrade
|
| Return on Assets (ROA) | 8.96% | 9.44% | 11.64% | 13.54% | 12.65% | 13.64% | Upgrade
|
| Return on Capital (ROIC) | 13.84% | 14.05% | 17.04% | 19.61% | 18.04% | 19.12% | Upgrade
|
| Return on Capital Employed (ROCE) | 20.80% | 20.90% | 25.70% | 29.10% | 30.20% | 29.70% | Upgrade
|
| Earnings Yield | 6.23% | 5.37% | 5.01% | 4.08% | - | - | Upgrade
|
| FCF Yield | 7.69% | 7.53% | 5.40% | 6.52% | - | - | Upgrade
|
| Dividend Yield | 5.48% | 4.91% | 4.38% | 3.58% | - | - | Upgrade
|
| Payout Ratio | 89.58% | 87.12% | 80.10% | 33.83% | 155.07% | 63.01% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | - | -2500.00% | Upgrade
|
| Total Shareholder Return | 5.48% | 4.91% | 4.38% | 3.58% | - | -2500.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.